Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian Cancer.
van der Burg ME, ten Bokkel Huinink WW, Vriesendorp R, van Oosterom AT, Neijt JP, Vermorken JB, van Putten WL, Kooiman A. van der Burg ME, et al. Among authors: van putten wl, van oosterom at. Eur J Cancer Clin Oncol. 1987 Jul;23(7):997-8. doi: 10.1016/0277-5379(87)90348-8. Eur J Cancer Clin Oncol. 1987. PMID: 3666002
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group.
Aapro MS, van Wijk FH, van der Burg ME, ten Bokkel Huinink W, Vergote I, Guastalla JP, Rosso R, Kobierska A, Beex LV, Namer M, Splinter TE, Vermorken JB. Aapro MS, et al. Among authors: van wijk fh, van der burg me. Eur J Cancer. 2003 May;39(8):1141-3. doi: 10.1016/s0959-8049(03)00198-9. Eur J Cancer. 2003. PMID: 12736114 Clinical Trial.
Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute.
ten Bokkel Huinink WW, Dalesio O, Rodenhuis S, Dubbelman R, Hilton A, Franklin H, Koier I, van Tinteren H, van der Burg ME, van Oosterom AT, et al. ten Bokkel Huinink WW, et al. Among authors: van oosterom at, van tinteren h, van der burg me. Semin Oncol. 1992 Feb;19(1 Suppl 2):99-101. Semin Oncol. 1992. PMID: 1411634 Clinical Trial.
Multicenter phase II study of spiroplatin.
Tanis BC, Vermorken JB, ten Bokkel Huinink WW, van Oosterom AT, Splinter TA, Vendrik KJ, Sleijfer DT, van der Burg ME, van der Putten E, Pinedo HM. Tanis BC, et al. Among authors: van der putten e, van oosterom at, van der burg me. Oncology. 1992;49(2):99-103. doi: 10.1159/000227020. Oncology. 1992. PMID: 1574259 Clinical Trial.
Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.
Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Willemse PH, Vermorken JB, van Lindert AC, Heintz AP, Aartsen E, van Lent M, et al. Neijt JP, et al. Among authors: van lindert ac, van lent m, van oosterom at, van der burg me. Eur J Cancer. 1991;27(11):1367-72. doi: 10.1016/0277-5379(91)90011-2. Eur J Cancer. 1991. PMID: 1835850 Clinical Trial.
151 results